1,1-dichloroethene increases expression ISO Ncapd2 (Mus musculus) 6480464 vinylidene chloride results in increased expression of NCAPD2 mRNA CTD PMID:26682919 1,2-dimethylhydrazine multiple interactions ISO Ncapd2 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NCAPD2 mRNA CTD PMID:22206623 1,2-dimethylhydrazine affects expression ISO Ncapd2 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine affects the expression of NCAPD2 mRNA CTD PMID:22206623 17alpha-ethynylestradiol affects expression ISO Ncapd2 (Mus musculus) 6480464 Ethinyl Estradiol affects the expression of NCAPD2 mRNA CTD PMID:17555576 17beta-estradiol increases expression ISO NCAPD2 (Homo sapiens) 6480464 Estradiol results in increased expression of NCAPD2 mRNA CTD PMID:16474171 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of NCAPD2 mRNA CTD PMID:32145629 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Ncapd2 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO Ncapd2 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Ncapd2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of NCAPD2 mRNA CTD PMID:19770486 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of NCAPD2 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Ncapd2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of NCAPD2 mRNA CTD PMID:21570461 2-hydroxypropanoic acid decreases expression ISO NCAPD2 (Homo sapiens) 6480464 Lactic Acid results in decreased expression of NCAPD2 mRNA CTD PMID:30851411 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of NCAPD2 mRNA CTD PMID:24780913 acrolein multiple interactions ISO NCAPD2 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of NCAPD2 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of NCAPD2 mRNA CTD PMID:32699268 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of NCAPD2 mRNA CTD PMID:28959563 acrylamide decreases expression ISO NCAPD2 (Homo sapiens) 6480464 Acrylamide results in decreased expression of NCAPD2 mRNA CTD PMID:32763439 adefovir pivoxil increases expression ISO NCAPD2 (Homo sapiens) 6480464 adefovir dipivoxil results in increased expression of NCAPD2 mRNA CTD PMID:25596134 all-trans-retinoic acid decreases expression ISO NCAPD2 (Homo sapiens) 6480464 Tretinoin results in decreased expression of NCAPD2 mRNA CTD PMID:33167477 alpha-pinene multiple interactions ISO NCAPD2 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of NCAPD2 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of NCAPD2 mRNA CTD PMID:32699268 amitrole increases expression EXP 6480464 Amitrole results in increased expression of NCAPD2 mRNA CTD PMID:30047161 arsenite(3-) decreases expression ISO Ncapd2 (Mus musculus) 6480464 arsenite results in decreased expression of NCAPD2 mRNA CTD PMID:18929588 arsenite(3-) multiple interactions ISO NCAPD2 (Homo sapiens) 6480464 arsenite inhibits the reaction [G3BP1 protein binds to NCAPD2 mRNA] CTD PMID:32406909 benzo[a]pyrene decreases expression ISO Ncapd2 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of NCAPD2 mRNA CTD PMID:19770486 benzo[a]pyrene increases methylation ISO NCAPD2 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of NCAPD2 5' UTR CTD PMID:27901495 benzo[a]pyrene increases expression ISO Ncapd2 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of NCAPD2 mRNA CTD PMID:22228805 benzo[a]pyrene diol epoxide I decreases expression ISO NCAPD2 (Homo sapiens) 6480464 7 more ... CTD PMID:20018196 and PMID:20382639 benzo[b]fluoranthene increases expression ISO Ncapd2 (Mus musculus) 6480464 benzo(b)fluoranthene results in increased expression of NCAPD2 mRNA CTD PMID:26377693 bis(2-chloroethyl) sulfide decreases expression ISO NCAPD2 (Homo sapiens) 6480464 Mustard Gas results in decreased expression of NCAPD2 mRNA CTD PMID:25102026 bisphenol A increases expression ISO NCAPD2 (Homo sapiens) 6480464 bisphenol A results in increased expression of NCAPD2 mRNA CTD PMID:16474171 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of NCAPD2 mRNA CTD PMID:32145629 bisphenol A affects expression ISO NCAPD2 (Homo sapiens) 6480464 bisphenol A affects the expression of NCAPD2 mRNA CTD PMID:30903817 bisphenol A decreases expression ISO NCAPD2 (Homo sapiens) 6480464 bisphenol A results in decreased expression of NCAPD2 mRNA CTD PMID:29275510 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of NCAPD2 mRNA CTD PMID:25181051 cadmium atom decreases expression ISO NCAPD2 (Homo sapiens) 6480464 Cadmium results in decreased expression of NCAPD2 mRNA CTD PMID:24376830 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of NCAPD2 mRNA CTD PMID:33453195 cadmium dichloride affects expression ISO NCAPD2 (Homo sapiens) 6480464 Cadmium Chloride affects the expression of NCAPD2 mRNA CTD PMID:25596134 caffeine increases phosphorylation ISO NCAPD2 (Homo sapiens) 6480464 Caffeine results in increased phosphorylation of NCAPD2 protein CTD PMID:35688186 calcitriol decreases expression ISO NCAPD2 (Homo sapiens) 6480464 Calcitriol results in decreased expression of NCAPD2 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO NCAPD2 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of NCAPD2 mRNA CTD PMID:21592394 carbon nanotube affects expression ISO Ncapd2 (Mus musculus) 6480464 Nanotubes and Carbon affects the expression of NCAPD2 mRNA CTD PMID:25554681 carbon nanotube increases expression ISO Ncapd2 (Mus musculus) 6480464 Nanotubes and Carbon analog results in increased expression of NCAPD2 mRNA CTD PMID:25554681 chloroacetaldehyde affects expression ISO NCAPD2 (Homo sapiens) 6480464 chloroacetaldehyde affects the expression of NCAPD2 mRNA CTD PMID:25596134 cidofovir anhydrous affects expression ISO NCAPD2 (Homo sapiens) 6480464 Cidofovir affects the expression of NCAPD2 mRNA CTD PMID:25596134 cisplatin increases phosphorylation ISO Ncapd2 (Mus musculus) 6480464 Cisplatin results in increased phosphorylation of NCAPD2 protein CTD PMID:22006019 cisplatin increases expression ISO NCAPD2 (Homo sapiens) 6480464 Cisplatin results in increased expression of NCAPD2 mRNA CTD PMID:27392435 cobalt dichloride decreases expression ISO NCAPD2 (Homo sapiens) 6480464 cobaltous chloride results in decreased expression of NCAPD2 mRNA CTD PMID:19320972 copper atom multiple interactions ISO NCAPD2 (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in decreased expression of NCAPD2 mRNA CTD PMID:20971185 copper(0) multiple interactions ISO NCAPD2 (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in decreased expression of NCAPD2 mRNA CTD PMID:20971185 copper(II) sulfate decreases expression ISO NCAPD2 (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of NCAPD2 mRNA CTD PMID:19549813 corticosterone decreases expression EXP 6480464 Corticosterone results in decreased expression of NCAPD2 mRNA CTD PMID:15755911 coumarin increases phosphorylation ISO NCAPD2 (Homo sapiens) 6480464 coumarin results in increased phosphorylation of NCAPD2 protein CTD PMID:35688186 coumestrol increases expression ISO NCAPD2 (Homo sapiens) 6480464 Coumestrol results in increased expression of NCAPD2 mRNA CTD PMID:19167446 CU-O LINKAGE decreases expression ISO NCAPD2 (Homo sapiens) 6480464 cupric oxide results in decreased expression of NCAPD2 mRNA CTD PMID:22077320 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of NCAPD2 mRNA CTD PMID:26577399 cyclosporin A decreases expression ISO Ncapd2 (Mus musculus) 6480464 Cyclosporine results in decreased expression of NCAPD2 mRNA CTD PMID:19770486 cyclosporin A decreases expression ISO NCAPD2 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of NCAPD2 mRNA CTD PMID:20106945 more ... diallyl trisulfide decreases expression ISO NCAPD2 (Homo sapiens) 6480464 diallyl trisulfide results in decreased expression of NCAPD2 mRNA CTD PMID:34995734 dibenz[a,h]anthracene increases expression ISO Ncapd2 (Mus musculus) 6480464 1 more ... CTD PMID:26377693 dibutyl phthalate decreases expression ISO Ncapd2 (Mus musculus) 6480464 Dibutyl Phthalate results in decreased expression of NCAPD2 mRNA CTD PMID:21266533 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of NCAPD2 mRNA CTD PMID:21266533 dicrotophos increases expression ISO NCAPD2 (Homo sapiens) 6480464 dicrotophos results in increased expression of NCAPD2 mRNA CTD PMID:28302478 dioxygen decreases expression ISO NCAPD2 (Homo sapiens) 6480464 Oxygen deficiency results in decreased expression of NCAPD2 mRNA CTD PMID:25596134 dorsomorphin multiple interactions ISO NCAPD2 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO NCAPD2 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of NCAPD2 mRNA CTD PMID:29803840 enzyme inhibitor multiple interactions ISO NCAPD2 (Homo sapiens) 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of NCAPD2 protein CTD PMID:23301498 folic acid multiple interactions ISO Ncapd2 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NCAPD2 mRNA CTD PMID:22206623 FR900359 affects phosphorylation ISO NCAPD2 (Homo sapiens) 6480464 FR900359 affects the phosphorylation of NCAPD2 protein CTD PMID:37730182 genistein increases expression ISO NCAPD2 (Homo sapiens) 6480464 Genistein results in increased expression of NCAPD2 mRNA CTD PMID:16474171 hexadecanoic acid decreases phosphorylation ISO NCAPD2 (Homo sapiens) 6480464 Palmitic Acid results in decreased phosphorylation of NCAPD2 protein CTD PMID:28073184 ifosfamide increases expression ISO NCAPD2 (Homo sapiens) 6480464 Ifosfamide results in increased expression of NCAPD2 mRNA CTD PMID:25596134 isobutanol multiple interactions ISO NCAPD2 (Homo sapiens) 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of NCAPD2 mRNA CTD PMID:29432896 ivermectin decreases expression ISO NCAPD2 (Homo sapiens) 6480464 Ivermectin results in decreased expression of NCAPD2 protein CTD PMID:32959892 leflunomide decreases expression ISO NCAPD2 (Homo sapiens) 6480464 leflunomide results in decreased expression of NCAPD2 mRNA CTD PMID:28988120 lipopolysaccharide multiple interactions ISO NCAPD2 (Homo sapiens) 6480464 [NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of NCAPD2 mRNA CTD PMID:35877022 metformin increases expression EXP 6480464 Metformin results in increased expression of NCAPD2 mRNA CTD PMID:25596134 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of NCAPD2 mRNA CTD PMID:22584684 methimazole increases expression EXP 6480464 Methimazole results in increased expression of NCAPD2 mRNA CTD PMID:30047161 miconazole increases expression ISO Ncapd2 (Mus musculus) 6480464 Miconazole results in increased expression of NCAPD2 mRNA CTD PMID:27462272 N(4)-hydroxycytidine decreases expression ISO Ncapd2 (Mus musculus) 6480464 N(4)-hydroxycytidine results in decreased expression of NCAPD2 mRNA CTD PMID:37748715 naphthalene increases expression ISO Ncapd2 (Mus musculus) 6480464 naphthalene results in increased expression of NCAPD2 mRNA CTD PMID:18978301 nickel atom decreases expression ISO NCAPD2 (Homo sapiens) 6480464 Nickel results in decreased expression of NCAPD2 mRNA CTD PMID:23195993 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of NCAPD2 mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of NCAPD2 mRNA CTD PMID:25729387 ozone decreases expression ISO Ncapd2 (Mus musculus) 6480464 Ozone results in decreased expression of NCAPD2 mRNA CTD PMID:24336422 ozone multiple interactions ISO Ncapd2 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of NCAPD2 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in increased expression of NCAPD2 mRNA CTD PMID:27106289 and PMID:34911549 ozone multiple interactions ISO NCAPD2 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of NCAPD2 mRNA more ... CTD PMID:32699268 palbociclib decreases expression ISO NCAPD2 (Homo sapiens) 6480464 palbociclib results in decreased expression of NCAPD2 mRNA CTD PMID:22869556 paracetamol affects expression ISO Ncapd2 (Mus musculus) 6480464 Acetaminophen affects the expression of NCAPD2 mRNA CTD PMID:17562736 paracetamol decreases expression ISO NCAPD2 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of NCAPD2 mRNA CTD PMID:29067470 paracetamol increases expression ISO NCAPD2 (Homo sapiens) 6480464 Acetaminophen results in increased expression of NCAPD2 mRNA CTD PMID:22230336 PCB138 multiple interactions ISO Ncapd2 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 perfluorononanoic acid decreases expression ISO NCAPD2 (Homo sapiens) 6480464 perfluoro-n-nonanoic acid results in decreased expression of NCAPD2 mRNA CTD PMID:32588087 perfluorooctanoic acid decreases expression ISO NCAPD2 (Homo sapiens) 6480464 perfluorooctanoic acid results in decreased expression of NCAPD2 protein CTD PMID:26879310 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of NCAPD2 protein CTD PMID:34958885 phenobarbital affects expression ISO Ncapd2 (Mus musculus) 6480464 Phenobarbital affects the expression of NCAPD2 mRNA CTD PMID:23091169 phenylmercury acetate decreases expression ISO NCAPD2 (Homo sapiens) 6480464 Phenylmercuric Acetate results in decreased expression of NCAPD2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO NCAPD2 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NCAPD2 mRNA CTD PMID:27188386 pirinixic acid decreases expression ISO Ncapd2 (Mus musculus) 6480464 pirinixic acid results in decreased expression of NCAPD2 mRNA CTD PMID:17426115 pirinixic acid increases expression ISO Ncapd2 (Mus musculus) 6480464 pirinixic acid results in increased expression of NCAPD2 mRNA CTD PMID:23811191 pregnenolone 16alpha-carbonitrile increases expression ISO Ncapd2 (Mus musculus) 6480464 Pregnenolone Carbonitrile results in increased expression of NCAPD2 mRNA CTD PMID:22698814 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of NCAPD2 mRNA CTD PMID:30047161 propanal decreases expression ISO NCAPD2 (Homo sapiens) 6480464 propionaldehyde results in decreased expression of NCAPD2 mRNA CTD PMID:26079696 rac-lactic acid decreases expression ISO NCAPD2 (Homo sapiens) 6480464 Lactic Acid results in decreased expression of NCAPD2 mRNA CTD PMID:30851411 resveratrol multiple interactions ISO NCAPD2 (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of NCAPD2 mRNA CTD PMID:23557933 SB 431542 multiple interactions ISO NCAPD2 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide increases expression ISO Ncapd2 (Mus musculus) 6480464 Silicon Dioxide results in increased expression of NCAPD2 mRNA CTD PMID:29341224 sodium arsenite increases expression ISO NCAPD2 (Homo sapiens) 6480464 sodium arsenite results in increased expression of NCAPD2 mRNA CTD PMID:34032870 Soman increases expression EXP 6480464 Soman results in increased expression of NCAPD2 mRNA CTD PMID:19281266 sulfadimethoxine increases expression EXP 6480464 Sulfadimethoxine results in increased expression of NCAPD2 mRNA CTD PMID:30047161 sunitinib decreases expression ISO NCAPD2 (Homo sapiens) 6480464 Sunitinib results in decreased expression of NCAPD2 mRNA CTD PMID:31533062 tert-butyl hydroperoxide decreases expression ISO NCAPD2 (Homo sapiens) 6480464 tert-Butylhydroperoxide results in decreased expression of NCAPD2 mRNA CTD PMID:15336504 testosterone multiple interactions ISO NCAPD2 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of NCAPD2 mRNA CTD PMID:21592394 testosterone decreases expression ISO NCAPD2 (Homo sapiens) 6480464 Testosterone results in decreased expression of NCAPD2 mRNA CTD PMID:21592394 tetrachloromethane increases expression ISO Ncapd2 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of NCAPD2 mRNA CTD PMID:27339419 and PMID:31919559 titanium dioxide increases expression ISO Ncapd2 (Mus musculus) 6480464 titanium dioxide results in increased expression of NCAPD2 mRNA CTD PMID:23557971 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of NCAPD2 mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of NCAPD2 mRNA CTD PMID:25729387 trichostatin A decreases expression ISO NCAPD2 (Homo sapiens) 6480464 trichostatin A results in decreased expression of NCAPD2 mRNA CTD PMID:26272509 trichostatin A multiple interactions ISO NCAPD2 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NCAPD2 mRNA CTD PMID:27188386 trimellitic anhydride increases expression ISO Ncapd2 (Mus musculus) 6480464 trimellitic anhydride results in increased expression of NCAPD2 mRNA CTD PMID:19042947 trovafloxacin decreases expression ISO Ncapd2 (Mus musculus) 6480464 trovafloxacin results in decreased expression of NCAPD2 mRNA CTD PMID:35537566 valproic acid decreases methylation ISO NCAPD2 (Homo sapiens) 6480464 Valproic Acid results in decreased methylation of NCAPD2 gene CTD PMID:29154799 valproic acid decreases expression ISO NCAPD2 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of NCAPD2 mRNA CTD PMID:28001369